These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Etiology and prevention of post-transfusion hepatitis upon systematic screening of donor sera]. Kirilenko VA; Anan'ev VA Vopr Virusol; 1989; 34(5):621-3. PubMed ID: 2609651 [No Abstract] [Full Text] [Related]
6. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Singh B; Verma M; Verma K Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208 [TBL] [Abstract][Full Text] [Related]
7. [Immunoradiometric analysis and the prevention of posttransfusion hepatitis B]. Leĭbenzon AS; Malakhova TS; Anan'ev VA; Viazov SO; Shchegolev AS Vopr Virusol; 1988; 33(3):292-4. PubMed ID: 3176430 [TBL] [Abstract][Full Text] [Related]
8. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention. Polesky HF; Hanson M Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449 [TBL] [Abstract][Full Text] [Related]
9. [Comparative studies of the distribution of hepatitis B markers among blood donors and patients with post-transfusion hepatitis in the city of Sofia]. Gubev E; Rashkov R; Dimitrova T; Sharankov N; Andonov A Vutr Boles; 1987; 26(3):38-43. PubMed ID: 3617705 [TBL] [Abstract][Full Text] [Related]
10. HBV--status in professional blood donors in north India. Irshad M; Singh YN; Acharya SK Trop Gastroenterol; 1992; 13(3):112-4. PubMed ID: 1488797 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc. Hopkins R; Kane E; Robertson AE; Haase G Med Lab Sci; 1982 Jan; 39(1):61-2. PubMed ID: 7098783 [No Abstract] [Full Text] [Related]
12. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary? Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408 [TBL] [Abstract][Full Text] [Related]
13. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection. Pintera J Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608 [TBL] [Abstract][Full Text] [Related]
14. [A follow-up investigation of 12 blood transfusion cases from HBsAg-positive donors]. Li FS; Yan Y; Pan NS Zhonghua Nei Ke Za Zhi; 1986 Jul; 25(7):407-8, 444-5. PubMed ID: 3803056 [No Abstract] [Full Text] [Related]
15. Transfusions and hepatitis: update in '78. Grady GF N Engl J Med; 1978 Jun; 298(25):1413-5. PubMed ID: 652008 [No Abstract] [Full Text] [Related]
16. 'How frequent is posttranfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature? Vox Sang; 1977; 32(6):346-63. PubMed ID: 898833 [TBL] [Abstract][Full Text] [Related]
17. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069 [TBL] [Abstract][Full Text] [Related]
18. [HBeAg and anti-HBe levels in HBsAg positive blood donors]. Hasçelik G; Günalp A Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096 [TBL] [Abstract][Full Text] [Related]
19. Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification. Pintera J; Krácmar C; Pinterová A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):415-25. PubMed ID: 2428716 [TBL] [Abstract][Full Text] [Related]
20. [HBsAg in the prevention of post-transfusion hepatitis. General notes and data on the incidence in Umbria]. Macrì M; Moretti R Minerva Med; 1977 Nov; 68(57):3833-7. PubMed ID: 593604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]